The development of vaccines against SARS-CoV-2 would be greatly facilitated by the
identification of immunological correlates of protection in humans. However, to date, studies …

Abstract Background Coronavirus disease 2019 (COVID-19) and dengue fever are difficult
to distinguish given shared clinical and laboratory features. Failing to consider COVID-19 …

Abstract Background Commercially available SARS-CoV-2 serological assays based on
different viral antigens have been approved for the qualitative determination of anti-SARS …

Background In the context of the COVID-19 pandemic, numerous new serological test
systems for the detection of anti-SARS-CoV-2 antibodies rapidly have become available …

Accurate assays for the detection of antibodies to SARS-CoV-2 (severe acute respiratory
syndrome coronavirus 2) are essential for the control of the COVID-19 (coronavirus disease …

The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) has
been followed by the rapid development of antibody tests. To assess the utility of the tests for …

Background It is unknown whether a positive serology result correlates with protective
immunity against SARS-CoV-2. There are also concerns regarding the low positive …

Nucleocapsid (N) encoded by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) plays key roles in the replication cycle and is a critical serological marker. Here, we …

Background Many commercial assays, of different designs, detecting SARS-CoV-2-specific
antibodies exist but with little experience with them. Objectives The aim of this study was to …

Background For epidemiologic, social and economic reasons, assessment of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection prevalence and immunity are …